Etanercept for the treatment of severe childhood psoriasis [3]

British Journal of Dermatology

Volumn 154, Issue 1, 2006, Pages 181-183

  Papoutsaki, M ^a   Costanzo, A ^a   Mazzotta, A ^a   Gramiccia, T ^a   Soda, R ^a   Chimenti, S ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ETANERCEPT; ETRETIN; IMMUNOGLOBULIN G1; KERATOLYTIC AGENT; RETINOID; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ABDOMINAL PAIN; ADOLESCENT; ATOPIC DERMATITIS; BACTERIAL ARTHRITIS; CASE REPORT; CHILD; CHILDHOOD DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL INFECTION; HUMAN; INJECTION SITE REACTION; LETTER; LUPUS LIKE SYNDROME; MALE; NAUSEA; OPTIC NEURITIS; PATIENT REFERRAL; PHARYNGITIS; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; PUSTULAR ERYTHRODERMIC GENERALIZED PSORIASIS; PUSTULOSIS PALMOPLANTARIS; RETREATMENT; RHINITIS; TREATMENT DURATION; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION; UVEITIS; VOMITING;

ADOLESCENT; CHILD; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 33644882511     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06982.x     Document Type: Letter

References (13)

1. Ritchie DM Boyle JA McInnes JM et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis Q J Med 1968 37 393 406
2. Leonardi CL Powers JL Matheson RT et al. Etanercept as monotherapy in the treatment of psoriasis N Engl J Med 2003 349 2014 22
3. Mease PJ Goffe BS Metz J et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial Lancet 2000 356 385 90
4. Moreland LW Schiff MH Baumgartner SW et al. Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial Ann Intern Med 1999 130 478 86
5. Wilkinson N Jackson G Gardner-Medwin J Biologic therapies for juvenile arthritis Arch Dis Child 2003 88 186 91
6. Lahdenne P Vahasalo P Honkanen V Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study Ann Rheum Dis 2003 62 245 7
7. Lovell DJ Giannini EH Reiff A et al. for the Pediatric Rheumatology Collaborative Study Group. Etanercept in children with polyarticular juvenile rheumatoid arthritis N Engl J Med 2000 342 763 9
8. Tauber T Daniel D Barash J et al. Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis Rheumatology (Oxford) 2005 44 405
9. Sawar H Espinoza LR Gedalia A Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis J Rheumatol 2004 31 623
10. Mangge H Gindl S Kenzian H et al. Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapy J Rheumatol 2003 30 2506 7
11. Haskes PJ Shajrawi I Sarcoid-related uveitis occurring during etanercept therapy Clin Exp Rheumatol 2003 21 645 6
12. Lepore L Marchetti F Facchini S et al. Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis Clin Exp Rheumatol 2003 21 276 7
13. Elwood RL Pelszynski MM Corman LI Multifocal septic arthritis and osteomyelitis caused by group A Streptococcus in a patient receiving immunomodulating therapy with etanercept Pediatr Infect Dis J 2003 22 286 8